Reference Library

Complete References

All medical claims on this site are based on the sources below. You can filter by category or search by keyword.

Each reference includes a DOI link for direct access to the original paper.

参考文献库

共 22 条文献

Hudelist et al.(2026)

CPA-associated meningioma in transgender women

eClinicalMedicine

DOI: 10.1016/j.eclinm.2026.103791

Poage AC et al.(2026)

Subcutaneous vs Intramuscular Estradiol Valerate Injection

Pharmacy

DOI: 10.3390/pharmacy14010013

Kanin M et al.(2025)

Injectable Estradiol Dosing Regimens

Journal of the Endocrine Society

DOI: 10.1210/jendso/bvaf004

Misakian AL et al.(2025)

Injectable Estradiol Monotherapy in Transgender Individuals

Endocrine Practice

DOI: 10.1016/j.eprac.2025.07.002

Rothman MS et al.(2024)

Injectable Estradiol Dosing in Transgender Individuals

Transgender Health

DOI: 10.1089/trgh.2023.0209

Herndon JS et al.(2023)

Subcutaneous vs Intramuscular Estradiol Valerate

Endocrine Practice

DOI: 10.1016/j.eprac.2023.02.006

富士製薬(2023)

プロギノン・デポー添付文書

PMDA

Link

Coleman E et al.(2022)

Standards of Care for the Health of Transgender and Gender Diverse People, Version 8

International Journal of Transgender Health

DOI: 10.1080/26895269.2022.2100644

Lee et al.(2022)

Cyproterone acetate and meningioma risk

Scientific Reports

DOI: 10.1038/s41598-022-05773-z

de Blok CJM et al.(2021)

Amsterdam cohort 50-year follow-up

The Lancet Diabetes & Endocrinology

DOI: 10.1016/S2213-8587(21)00185-6

Patel et al.(2021)

Breast development in transgender women on hormone therapy

Transgender Health

DOI: 10.1089/trgh.2020.0057

Aly(2021)

Injectable Estradiol Meta-Analysis

Transfeminine Science

Link

Meyer et al.(2020)

Safety and rapid efficacy of guideline-based gender-affirming hormone therapy

European Journal of Endocrinology

DOI: 10.1530/EJE-19-0463

EMA(2020)

Restrictions on use of cyproterone due to meningioma risk

European Medicines Agency

Link

Vinogradova Y et al.(2019)

Use of hormone replacement therapy and risk of venous thromboembolism

BMJ

DOI: 10.1136/bmj.k4810

Prior JC(2019)

Progesterone is important for transgender women's therapy

The Journal of Clinical Endocrinology & Metabolism

DOI: 10.1210/jc.2018-01777

Canonico M et al.(2018)

Hormone therapy and venous thromboembolism: an updated overview

Maturitas

DOI: 10.1016/j.maturitas.2015.06.040

Hembree WC et al.(2017)

Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons

The Journal of Clinical Endocrinology & Metabolism

DOI: 10.1210/jc.2017-01658

Deutsch(2016)

Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People

UCSF Gender Affirming Health Program

Link

Kuhl(2005)

Pharmacology of estrogens and progestogens: influence of different routes of administration

Climacteric

DOI: 10.1080/13697130500148875

Price et al.(1997)

Sublingual estradiol pharmacokinetics

Obstetrics & Gynecology

DOI: 10.1016/S0029-7844(96)00513-3

Oriowo MA et al.(1980)

Pharmacokinetics of Estradiol Esters

Contraception

DOI: 10.1016/S0010-7824(80)80018-7